Cleerly Analysis - USING the ADDED power of A.I. for risk assessment  

Overview

It's time to measure the actual disease, atherosclerosis, not rely on signs, surrogates, or sequelae of disease. Cleerly’s AI-enabled evaluation of Coronary CT Angiography identifies, characterizes, and quantifies plaque buildup to support physicians in determining a patient's risk of a heart attack and developing a treatment plan to improve heart health.  

 

 

   

Learn more about Cleerly's AI-enabled technology that identifies the presence, type, and amount of heart disease which improves understanding of heart attack risk, and empowers clinicians to personalize treatment for better outcomes.

 

Sharon Bruno, 47, is a registered nurse in Florida and vice president of partnerships at a provider of self-insured health plans, who was worried about her heart health due to her family history.